Arrowhead Research Corporation
is a holding company that forms, acquires, and operates portfolio companies commercializing innovative nanotechnologies. By working closely with leading scientists and universities, Arrowhead identifies the latest advances in nanotechnology and matches them with product development opportunities in high-growth markets. The Company is currently focused on the electronics and biotech industries.
Providing strategic management, financing, and operational services to its portfolio companies, Arrowhead takes an active role in their development, keeping the business and technical development teams at the portfolio level focused on near term revenue opportunities and capital efficiency.
Arrowhead’s strategy is to maintain or build a majority ownserhip position in each portfolio company, thus providing significant exposure to their growth. Arrowhead’s ultimate goal is to monetize the value of its subsidiaries through an initial public offering of subsidiary stock or a sale of a subsidiary to another company.
more
White Paper
CALAA-01 Results Show Delivery Technology to Meet Critical Need in RNAi Therapeutics, Putting Arrowhead in Position to Monetize Asset. Read (PDF)
2010 Annual Meeting of Shareholders
June 16, 2010 at 10:00 AM PT
Sheraton Pasadena
303 E. Cordova Street, Pasadena, CA 91101
Click here for recording of presentation
by CEO Chris Anzalone
About Nanotechnology
Nanotechnology is the investigation and design of materials and devices at the atomic and molecular levels. The engineering of materials and devices at the nanoscale is expected to unleash fundamental paradigm shifts in a range of different industries. more
News & Press Releases
NEWS RELEASE / June 23, 2010
ARROWHEAD ANNOUNCES CLOSING OF $8.65 MILLION REGISTERED DIRECT OFFERING more
Unique Value Proposition
Efficient holding company capital structure
Near-term commercialization of innovative products
Large addressable market opportunities in nanotechnology
Leading IP position in nanotechnology

